Kayne Anderson Rudnick Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.8K | Buy |
304
+165
| +119% | +$17.8K | ﹤0.01% | 640 |
|
|
2025
Q1 | $14K | Sell |
139
-51
| -27% | -$5.15K | ﹤0.01% | 672 |
|
|
2024
Q4 | $17K | Buy |
190
+51
| +37% | +$4.57K | ﹤0.01% | 646 |
|
|
2024
Q3 | $11.6K | Sell |
139
-13
| -9% | -$1.09K | ﹤0.01% | 665 |
|
|
2024
Q2 | $11.7K | Buy |
152
+13
| +9% | +$1K | ﹤0.01% | 623 |
|
|
2024
Q1 | $9.52K | Buy |
139
+20
| +17% | +$1.37K | ﹤0.01% | 632 |
|
|
2023
Q4 | $6.88K | Buy |
119
+50
| +72% | +$2.89K | ﹤0.01% | 637 |
|
|
2023
Q3 | $3.64K | Hold |
69
| – | – | ﹤0.01% | 643 |
|
|
2023
Q2 | $3.73K | Buy |
+69
| New | +$3.73K | ﹤0.01% | 640 |
|
|
2022
Q2 | – | Sell |
-157
| Closed | -$7K | – | 613 |
|
|
2022
Q1 | $7K | Buy |
157
+139
| +772% | +$6.2K | ﹤0.01% | 543 |
|
|
2021
Q4 | $1K | Buy |
+18
| New | +$1K | ﹤0.01% | 602 |
|
|
2020
Q2 | – | Sell |
-50
| Closed | -$2K | – | 552 |
|
|
2020
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 520 |
|
|
2019
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 552 |
|
|
2019
Q3 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 502 |
|